IRAK3 and lung carcinoma: reported that TAMs express significantly higher levels of interleukin receptor‐associated kinase (IRAK)‐M, a potent negative regulator of TLR signaling expressed in macrophages, compared with peritoneal macrophages in mice models of lung cancer.